Effect of bioactive peptide of Carapax Trionycis on TGF-β1- induced intracellular events in hepatic stellate cells

Journal of Ethnopharmacology

Volumn 148, Issue 1, 2013, Pages 69-73

  Tang, Yingpin ^a   Hu, Chunling ^a   Liu, Yanwen ^a  

^a HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Carapax Trionycis extract peptide (CTEP); Extracellular matrix (ECM); Hepatic stellate cells (HSCs); TGF 1 Smad

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; CARAPAX TRIONYCIS EXTRACT PEPTIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; INTERSTITIAL COLLAGENASE; SMAD3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; LIVER FIBROSIS; LIVER PROTECTION; PROTEIN EXPRESSION; STELLATE CELL; WESTERN BLOTTING;

ANIMAL SHELLS; ANIMALS; BIOLOGICAL PRODUCTS; CELL LINE; CELL PROLIFERATION; COLLAGEN TYPE I; COLLAGEN TYPE III; HEPATIC STELLATE CELLS; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 1; PEPTIDES; RATS; REPTILIAN PROTEINS; SMAD3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA1; TURTLES;

ANIMALIA;

EID: 84878313492     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.03.067     Document Type: Article

References (23)

1. R. Bataller, and D.A. Brenner Liver fibrosis The Journal of Clinical Investigation 115 2005 209 218
2. K. Breitkopt, S. Haas, and E. Wiercinska Anti-TGF-beta strategies for the treatment of chronic liver disease Alcoholism-Clinical and Experimental Research 29 2005 121s 131s
3. J.M. Chen, Y.P. Yang, and D.Y. Chen Efficacy and safety of Fufang Biejia Ruangan tablet in patients with chronic hepatitis B complicated with hepatic fibrosis Chinese Journal of Experimental and Clinical Virology 21 2007 358 360
4. S. Dooley, J. Hamzavi, and K. Breitkopf Smad 7 prevents activation of hepatic stellate cells and liver fibrosis in rats Gastroenterology 125 2003 178 191
5. J.A. Fallowfield Therapeutic targets in liver fibrosis American Journal of Physiology, Gastrointestinal and Liver Physiology 300 2011 G709 G715
6. J.R. Gao, Y.W. Liu, C.Y. Li, and C.Z. Zhang Identification of the active material of anti-hepatic fibrosis from Amydae Carapax Chinese Journal of Hepatology 5 2010 346 352
7. J.R. Gao, Y.F. Zhu, and C.Z. Zhang Experimental study of Amydase Carapax decoction on provention and treatment of liver fibrosis in rats induced by two different causes Chinese Archives of Traditional Chinese Medicine 27 2009 1727 1733
8. J.R. Gao, C.Z. Zhang, and Y.W. Liu Experimental study of Amydase Carapax on prevention and treatment of liver fibrosis Chinese Archives of Traditional Chinese Medicine 26 2008 2462 2471
9. E.R. Garcia-Trevijano, M.J. Iraburu, L. Fontana, J.A. Dominguez-Rosales, A. Auster, A. Covarrubias-Pinedo, and M. Rojkind Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells Hepatology 29 1999 960 970
10. A.M. Gressner, and R. Weiskirchen Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets Journal of Cellular and Molecular Medicine 10 2006 76 99
11. S. Hemmann, and J. Graf Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies Journal of Hepatology 46 2007 955 975
12. V. Hernandez-Hea, and S.L. Friedman Pathogenesis of liver fibrosis Annual Review of Pathology 6 2011 425 456
13. J.P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ Journal of Clinical Investigation 117 2007 539 548
14. J.X. Jiang, K. Mikami, and S. Venugopal Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways Journal of Hepatology 51 2009 139 148
15. T. Knittel, and M. Mehde Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat Histochemistry and Cell Biology 113 2000 443 453
16. G. Latella, A. Vetuschi, R. Sferra, V. Catitti, A. Dangelo, and G. Zanninelli Targeted disruption of Smad 3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice Liver International 29 2009 997 1009
17. J. Liu, and H. Tan The preventive effects of heparin-superoxide dismutase on carbon tetrachloride-induced acute liver failure and hepatic fibrosis in mice Molecular and Cellular Biochemistry 327 2009 219 228
18. T. Luedde, and R.F. Schwabe NF-kB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nature reviews Gastroenterology & Hepatology 8 2011 108 118
19. C.C. Prosser, R.D. Yen, and J. Wu Molecular therapy for hepatic injury and fibrosis: where are we? World Journal of Gastroenterology 12 2006 509 515
20. J.N. Shi, J.W. Chen, and J.R. Gao Comparison on HPCE fingerprint of anti-liver fibrosis components in pre-and post-processed Trionyx Sinensis Carapace Chinese Journal of Information on TCM 18 2011 63 66
21. Y. Tan, Z.P. Lv, and X.C. Bai Traditional Chinese medicine Bao Gan Ning increase phosphorylation of CREB in liver fibrosis in vivo and in vitro Journal of Ethnopharmacology 105 2006 69 75
22. S. Tsukada, C.J. Parsons, and R.A. Rippe Mechanisms of liver fibrosis Clinica Chimica Acta 364 2006 33 60
23. Z.J. Zhao, Q. Qiu, and X.X. Zhang Effect of Compound Biejia Ruangan tablet on expressions of connective tissue growth factor mRNA and protein in kidney tissue of rats with adriamycin-induced nephropathy Journal of Chinese Integrative Medicine 5 2007 651 655